BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Feb 6, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-02-02

Reporting Person: Wood Mark (VP, Human Resources)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-02	Common Stock	M	6500	$26.49	Acquired	27134	Direct
2012-02-02	Common Stock	S	6500	$38.00	Disposed	20634	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-02	Stock Option (right to buy) Common Stock	$26.49	M	6500	Disposed	2021-05-11	Common Stock (6500)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on August 20, 2011.

F2: Original option grant vests 6/48th on November 12, 2011 and 1/48th each on the 12th of each month thereafter.